Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 144 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1431 8.2 months Metastatic and advanced urothelial carcinoma 5 Chemotherapy
Abramson Cancer Center of the University of Pennsylvania United States 9/2009
Treatment Details: Patients: This phase 2 study involved 151 metastatic or locally advanced urothelial carcinoma patients who had received prior platinum-based chemotherapy. The median patient age was 66 yea
 
1432 8.2 months Advanced malignant pleural mesothelioma 5 Biologic therapy
University of Western Australia Australia 9/2013
Treatment Details: Patients: This phase 2 study involved 30 advanced malignant pleural mesothelioma patients. The median patient age was 64 years and 27 were male. Treatment: Patients were treated with t
 
1433 8.2 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
University Medical Center Groningen Netherlands 11/2011
Treatment Details: Patients: This phase 3 study involved advanced non-small cell lung cancer patients, who had not been previously treated with chemotherapy and were divided into two separate treatment group
 
1434 8.2 months Advanced NSCLC 5 Chemotherapy
University Medical Center Groningen Netherlands 11/2011
Treatment Details: Patients: This phase 3 study involved advanced non-small cell lung cancer patients, who had not been previously treated with chemotherapy and were divided into two separate treatment group
 
1435 8.2 months Advanced Liver Cancer 5 Biologic therapy
National Taiwan University Hospital Taiwan Region 6/2015
Treatment Details: Patients: This phase 2 study involved advanced hepatocellular carcinoma patients who were divided into two separate treatment groups. Group A had 54 patients with a median age of 62.5 year
 
1436 8.1 months Advanced urothelial cancer 5 Chemotherapy
Kaiser Franz Josef Hospital Austria 1/2012
Treatment Details: Patients: This study involved advanced urothelial cancer patients who had not received prior chemotherapy. Patients were divided into two separate treatment groups. Group A included 119 p
 
1437 8.1 months Urothelial cancer 5 Biologic therapy
University Hospital Del Mar Spain 12/2011
Treatment Details: Patients: This phase II study involved 38 patients with untreated urothelial cancer. The median patient age was 75 years and 79% were male. Treatment: Patients were treated with the bi
 
1438 8.1 months Recurrent GBM 4 University of Texas M. D. Anderson Cancer Center United States 6/2003
Treatment Details: Patients: This Phase II study involved 88 patients with recurrent and progressive malignant gliomas (40 with glioblastoma multiforme (one had a gliosarcoma), 28 with anaplastic astrocytoma,
 
1439 8.1 months Advanced renal cell carcinoma 4 Chemotherapy
Immunotherapy
Tartu University Clinics Estonia 9/2004
Treatment Details: Patients: This Phase II study involved 25 patients with advanced renal cell carcinoma, 18 men and 7 women. The median age was 57.2 years. Patients had inoperable or metastatic tumors. Eig
 
1440 8.1 months colorectal (advanced) 5 Biologic therapy
University of Texas Medical Branch United States 7/2006
Treatment Details: Patients: This Phase II trial involved a total of 55 patients with metastatic colorectal cancer. There were 30 men and 25 women. The median age was 68.5. Forty-nine patients had prior sur
 
Page 144 of 187  | Previous Page  | Next Page